Axonics Modulation Technologies Proposes Terms For $100 Million IPO [Seeking Alpha]
BioLife Solutions, Inc. (BLFS)
Last biolife solutions, inc. earnings: 3/11 04:29 pm
Check Earnings Report
US:NASDAQ Investor Relations:
biolifesolutions.com
Company Research
Source: Seeking Alpha
Summary Quick Take Axonics Modulation Technologies ( AXNX ) intends to raise $100 million from the sale of its common stock in an IPO, per an amended registration statement . The company is developing a sacral neuromodulation device to treat a number of urinary tract conditions. AXNX is nearing U.S. approval, but the proposed IPO valuation isn't cheap and the firm faces significant, entrenched competition. Company & Technology Irvine, California-based Axonics Modulation was founded in 2013 to develop and market a minimally invasive rechargeable SNM (r-SNM) system for patients with overactive bladder [OAB], fecal incontinence [FI], and urinary retention [UR]. Management is headed by Director and CEO Raymond W. Cohen , who has been with the firm since 2013 and is currently Chairman at DYSIS Medical and Biolife Solutions. AMT has developed the Axonics r-SNM system which delivers mild electrical pulses to the targeted sacral nerve to restore norm
Show less
Read more
Impact Snapshot
Event Time:
BLFS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLFS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLFS alerts
High impacting BioLife Solutions, Inc. news events
Weekly update
A roundup of the hottest topics
BLFS
News
- BioLife Solutions Announces the Divestiture of its Stirling Freezer BusinessPR Newswire
- BioLife Solutions, Inc. (NASDAQ: BLFS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock.MarketBeat
- Investors in BioLife Solutions (NASDAQ:BLFS) have unfortunately lost 49% over the last three years [Yahoo! Finance]Yahoo! Finance
- When Will BioLife Solutions, Inc. (NASDAQ:BLFS) Become Profitable? [Yahoo! Finance]Yahoo! Finance
- BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences [Yahoo! Finance]Yahoo! Finance
BLFS
Earnings
- 2/29/24 - Miss
BLFS
Sec Filings
- 4/18/24 - Form 4
- 4/18/24 - Form 8-K
- 4/3/24 - Form 4
- BLFS's page on the SEC website